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TCT-544
The Safety and Feasibility of Sheathless Transradial Carotid Artery Stenting
(Comparing with Transbrachial Carotid Artery Stenting)
Hsiu-Yu Fang, Chiung-Jen Wu
Division of Cardiology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung
City, Taiwan
Background: Our pilot study had already evaluated the feasibility and safety of TRA
and TBA CAS using Catheter Looping And Retrograde Engagement Technique
(CLARET). The major limitation of TRA CAS is the inability to use large guiding
catheters (7Fr.) when radial artery size is too small. Before the sheathless technique,
we used TBA instead of TRA.
Methods: 33 patients with documented carotid artery stenosis and smaller radial artery,
whom were selected for CAS via sheathless TRA, and comparing with 61 patients
underwent CAS using TBA. Usual radial puncture with a 5Fr. sheath was introduced,
and 5Fr. Ikari-Lt 3.5 guiding was used for diagnostic cerebral angiography, and
changed to 7F Kimny-Rad guide via sheathless manner for CAS. Routine assessment
of radial artery patency was made either by Doppler or reverse Allen’s test at 1 month
(mo) and 6-mo after CAS.
Results: This sheathless TRA CAS technique offered 100% diagnostic and procedure
success. There were no baseline characteristics differences between TRA and TBA.
Only one patient (3.1%) experienced transient ischemia attack (TIA) during the
procedure and immediately recovery during hospitalization. There were no major
complications (major stroke or 30 day in-hospital death), or radial access site
complications (compartment syndrome, or acute blood loss need blood transfusion),
as compared with TBA CAS, composite end points occurred in 3/61 (4.9%) (one major
stroke and two pseudo-aneurysm required surgical repair). Mean hospital stay in TBA
was longer than TRA (10.9 ± 8.4 v.s. 8.3 ± 5.5 days, p=0.042). All radial arteries were
patent after CAS during 1-mo and 6-mo clinical follow-up.
Conclusion: The results showed that sheathless TRA CAS in patients with smaller
radial artery, is safe and technically feasible with acceptable low complications with
shorter hospital stay, Long-term radial patency was achieved at follow-up (6-mo) after
TRA CAS.
TCT-545
Carotid artery stenting in patients with and without contralateral stenosis (≥
50%)
Alexander Kypta, Clemens Steinwender, Klaus Kerschner, Robert Hofmann, Michael
Grund, Franz Leisch
General and University Teaching Hospital Linz Cardiovascular Division, Linz,
Austria
Background: The goal of this study was to evaluate the clinical and sonographic
outcome of patient undergoing carotid artery stenting (CAS) with and without
contralateral stenosis of (≥ 50%).
Methods: This retrospective study included 1035 patients (335 female/700 male, mean
age 70±9 years) undergoing percutaneous transluminal angioplasty and stenting of
CAS. The indications for CAS were symptomatic patients with a stenosis ≥60% or
asymptomatic patients with a stenosis ≥80%.There were 188 patients with contralateral
stenosis (CS) of ≥50% and 847 without (NoCS). Adverse events were defined as death,
stroke (≥24 hours), PRIND (≤72 hours). We compared the risk of procedural and long-
term adverse events (≥6 months) after the CAS. Binary instent restenosis was defined
by Doppler ultrasound with a restenosis of ≥50%.
Results: Technical success was achieved in 186 patients with CS (98.9%) and in 823
patients with NoCS (97.2%). A filter wire (Boston Scientific) was used in 51% of the
CS patients and in 56% of the NoCS patients (p<0.05).The risk of procedural adverse
events was 3.2% in the CS group and 2.8% in the NoCS group (p=ns). During a mean
follow-up period of 36 ± 6 months, asymptomatic binary instent restenosis occured in
22 (11.7%) of the CS patients, and in 50 (5.9%) of the NoCS patients (p<0.005). There
were 41 (21.8%) deaths (3 cerebral, 26 cardiac, 12 other) in the CS group and 184
(21.7%) in the NoCS group (15 cerebral, 92 cardiac, 77 other; p=ns).
Conclusion: CAS is feasible, safe and shows comparable procedural outcomes in
patients with or without contralateral stenosis. During long-term follow-up (36 months)
binary instent restenosis occurs significantly more frequent in patients with CS (11.7%)
than in patients with NoCS (5.9%) group (p<0.005).
TCT-546
Novel predictors for in-stent restenosis (ISR) after carotid artery stenting (CAS)
Roland Richard Macharzina, Christian Claus, Janine Schiek, Tanja Böhme, Aljosha
Rastan, Nian Fan, Uli Beschorner, Sebastian Sixt, Franz-Joseph Neumann, Thomas
Zeller
Angiology, Heart Center Bad Krozingen, Bad Krozingen, Germany
Background: ISR after CAS is a determinant of outcome. Knowledge about predictors
of ISR may contribute to improved patient selection. A prospective single-center CAS-
registry (KrozCar) was analysed regarding risc factors, stenosis-morphology,
neurological- as well as procedure-related variables to find predictors for ISR. We
hypothesized, that short- to mid-term ISR may be associated with independent
predictors.
Methods: 375 consecutive patients (pts), 282 men and 93 women were analysed.
Progression of disease was monitored at day 3, 30, 180 and 360 after CAS by duplex
ultrasound (DUS). Pts were seen by a neurologist before and after the procedure.
Restenosis was assessed by using standardized DUS criteria for identification of ≥50%
NASCET carotid stenosis. In case of contralateral occlusion, internal- to common
carotid peak velocity-ratio was used for grading at follow-up (FU). B-mode ultrasound
was used to determine plaque morphology prospectively. CAS was performed by a
single interventionalist. CAS technique was adapted to pertinent developments
regarding stents, protection devices and product performance within 12 years of
inclusion. Uni- and multivariate analyses were used for identification of independent
predictors for ISR. Statistics was with SPSS.
Results: 322 pts. completed clinical FU (86%). Post-hoc analysis of DUS prospective
pictorial online documentation was in 188 pts at 12 months. ISR rate was 9,1% (n=34)
in total at 12 months: 5,3% for 50-69% and 3,7% for >70% stenosis. Neurological
event was observed only once after occurrence of ISR. Univariate analysis of all
variables showed that calcified plaque (OR 4,73; P=0,003), shorter plaque-length (OR
3,45; P=0,018) and contralateral occlusion (OR 2,67; P=0,031) were associated with
ISR. On multivariate regression analysis all of these factors turned out to be
independent predictors for isr.
Conclusion: New independent predictors of ISR were found by detailed analysis of
ultrasound images in a cohort with moderate incidence of ISR. The results of this study
may be worth to be analysed in a large multicenter trial.
TCT-547
Transcatheter Laser Revascularization of Brain Vessels in the Treatment of
Vascular Dementia
Ivan V. Maksimovich
Clinic of Cardiovascular Diseases named after Most Holy John Tobolsky, Moscow,
Russian Federation
Background: The number of patients with cerebral vessels atherosclerosis is growing
around the world. The research purpose is the study of brain transcatheter laser
revascularization efficacy in the treatment of cerebral atherosclerosis accompanied by
vascular dementia.
Methods: The investigation included 665 patients 478 (71.87%) men, 187 (28.13%)
women aged 40-81 (average age 75) suffering from various types of atherosclerotic
lesions of brain vessels accompanied by vascular dementia. All the patients underwent
CT, MRI, SG, REG, MUGA. 639 (96.09%) patients underwent transcatheter treatment
revealing the following: 86 patients had macrofocal strokes, 74 medium focal strokes,
29 single microfocal strokes, 36 multiple microfocal strokes, 273 patients had
atherosclerotic lesions without strokes, 98 had arteriolosclerosis, 37 had atherosclerotic
parkinsonism, 6 had Binswanger’s disease. Of these, CDR-1 - 352 (55.09%), CDR-2
- 184 (28.79%), CDR-3 - 103 (16.12%) patients. For revascularization of main
intracranial arteries high-energy laser systems were used; for revascularization of distal
intracranial branches low-energy laser systems were used.
Results: A good immediate angiographic result manifested in the restoration of
vascular lumen and patency as well as collateral revascularization was achieved in 628
(98.27%) cases. Clinical results were dependent on the severity of ischemic lesion,
atherosclerosis spread, the severity of dementia and the timing of surgical intervention.
Good clinical result (Index Bartels-IB-100) in group CDR-1 was achieved in 282
(80.11%), CDR-2 in 81 (44.02%), CDR-3 in 9 (8.73%) cases. Satisfactory clinical
result (IB-70-80) in group CDR-1 was obtained in 53 (15.06%), CDR-2 in 62 (33.70%),
CDR-3 in 31 (30.09%) cases. Relatively satisfactory clinical result (IB-50-60) in CDR-
1 was obtained in 17 (4.83%), CDR-2 in 41 (22.28%), CDR-3 in 63 (61.16%) cases.
Conclusion: Evaluating the data obtained we can conclude that the method of
transcatheter laser revascularization of cerebral blood vessels is an effective one in the
treatment of atherosclerotic lesions of the brain accompanied by dementia.
TCT-548
Outcomes of Modern Endovascular Treatment of vein of Galen Malformations
in the Neonatal Period
Alejandro Berenstein
1Endovascular Neurosurgery, Roosevelt Hospital, New York, NY; 2Roosevelt
Hospital, New York, NY
Background: Untreated patients with neonatal presentation of vein of Galen
aneurismal malformations (AMVG) carry almost 100% morbidity and mortality,
usually from uncontrollable heart failure. We report our most recent patients requiring
neonatal interventional endovascular treatment.
Methods: A consecutive series of 16 neonatal patients presented with AMVG from
2005 to 2011. Nine were treated in the newborn period by transarterial liquid
embolization with cyanoacrylate tissue adhesive (NBCA) targeting the fistula sites via
percutaneous femoral artery access. The goal was to make their heart failure medically
manageable by reducing arteriovenous shunting. Patients returned for further
endovascular treatment at 6 to 9 months of age.
Results: Neonatal control of cardiac failure was achieved in 8/9 patients. One 1.5 kg.
premature baby expired after treatment due to diffuse intracranial hemorrhage. One
patient experienced a stroke and mild hemiparesis from a microcatheter rupture. 3/9
patients demonstrated post treatment asymptomatic intracranial hemorrhage.
Angiographic cure was documented at an average age of 23 months in 6/9 patients
after an average of 2.5 treatments. 5/6 of these patients have achieved normal
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milestones.1 patient has a mild motor and language delay,and the child with the
neonatal microcatheter rupture has a mild hemiparesis. The 2 children with residual
A-V shunting have planned further embolizations
Conclusion: Treatment of neonatal AMVG with modern endovascular techniques in
conjunction with specialized neuroanesthetic and neurointensive care results in
improved outcomes with cure and normal neurological development. Multiple stages
are often necessary. These patients require care by an interdisciplinary team in
specialized centers devoted to this group of diseases.
TCT-549
Selective Basilar Artery Thrombolysis For Posterior Territory Stroke: Acute
Stroke Registry From Western India
Kamaldeep Chawla, Keyur Buch
Cardiology, Sterling Hospital, Baroda, India
Background: Posterior territory strokes are not only difficult to diagnose appropriately
within early time frame but also to initiate early treatment.Basilar artery occlusion is
associated with a poor prognosis. However, the advent of high-quality, reliable, and
noninvasive technology (eg, MRI) has made its diagnosis possible early in the course
of the condition, which has illustrated that some patients with partial occlusion have
limited ischemic injury and, therefore, a better prognosis. We present our data of 31
patients treated within 3 hours to 12 hours time frame presenting with this condition.
Methods: Thirty one patients with clinical diagnosis of vertebro-basilar stroke
presented to our hospital were enrolled from Jan 2008 till date. After a Brain CT scan
report ruling out hemmorrhage, and performing an early MRI brain scan, these patients
underwent selective basilar artery thrombolysis with Actilyse (Boehringer)delivered
via a microcatheter in dose ranging 0.6mg/Kg to 0.9 mg/Kg body wt. All procedures
were performed via femoral artery route. Mechanical disruption of thrombus was
performed in selected cases. In all procedures, neurologist was present and procedures
performed by interventional cardioogist. In the ensuing 24 hrs. all patinets underwent
diffussion weighted MRI brain scan.
Results: Window period: 06 hrs Mean Age: 40 yrs (21 - 81) Survival: 66 % Acute
Mortality: 25 % NINDS score: 25 —> 12 Mean procedure time: 25 minutes 2 yrs
follow up data & *all tabulated results will be presented at conference
Conclusion: The morbidity and mortality of patients treated with intra-arterial
thrombolysis is not all that different versus intravenous thrombolysis, although
recanalization was achieved more frequently with intra-arterial thrombolysis. Selective
intra arterial thrombolysis for posterior territory strokes is feasible, safe and effective.
The procedures are best performed in context of neurologist and interventionalist
“team” perspective.
TCT-550
Carotid Stent Placement (CAS) with or without Debris Aspiration Prior to
Embolic Protection (EDP) Retrieval: A CHOICE Registry Subset Study
Thomas K Pow, Dilip S Arora, Timothy J Pow
Great Lakes Heart and Vascular Institute, Stevensville, MI
Background: EPD is mandatory in patients undergoing CAS placement due to risk of
cerebral embolization. Provisional debris aspiration to treat sluggish flow through a
packed filter prior to EPD retrieval has been reported. Despite EPD, CAS still has
increased risks of minor stroke compared to Carotid Endarterectomy. This may be due
to debris particles trapped in the column of blood below the EPD that may emboli at
the time of EPD retrieval. Routine debris aspiration during CAS placement prior to
EPD retrieval may reduce adverse and neurological complications by removing
potential embolic particles.
Methods: From 9/2007 to 6/2011, 94 patients had CAS under the CHOICE Registry
in our institution. The first 52 patients had CAS without aspiration (NoDAG) and the
2nd consecutive group of 42 patients had routine debris aspiration (DAG) prior to EPD
retrieval. All patients had NIH scale stroke exams prior to CAS, at 24hrs, and 30 days
post procedure. The CHOICE Registry data was reviewed to compare adverse events
and neurological complications between the NoDAG and the DAG group.
Results: All 94 patients had successful CAS with EPD per CHOICE protocol. The
DAG group also had successful aspiration using the Fetch or the Xpress-way catheter
by removing 20cc of blood prior to EPD retrieval. There are no major or minor strokes
reported in both groups. One patient died in the NoDAG within 30 days of the
procedure due to a cardiac event. Four patients in the NoDAG group had minor
neurological deficits (deviation by 1 point in the NIH scale) that occurred at 24 hours
and resolved at 30 days. There are no reported deaths or minor neurological deficits in
the DAG group. These yielded adverse events of 5/52 in the NoDAG and 0/42 in the
DAG with a p value of 0.06 using the Fisher’s Exact Probability Test.
Conclusion: Routine debris aspiration during CAS placement is safe and may reduce
minor transient neurological deficits by removing potential embolic particles before
EPD retrieval. Large scale clinical study is needed to evaluate routine use of debris
aspiration during CAS placement.
TCT-551
Inflammatory Markers Predict Future Cardiovascular Events in Patients
Undergoing Carotid Stenting
Francesco Versaci1, Francesco Prati2, Andrea Pacchioni1, Anna de Fazio3, Giovanni
A Chiariello4, Antonio Mugnolo1, Salvatore Saccà1, Carlo Penzo1, Bernhard
Reimers1
1Dipartimento di Cardiologia Ospedale Civile di Mirano – Venice, Mirano - Venice,
Italy; 2Unità Operativa Complessa di Cardiologia II, Ospedale San Giovanni, Rome,
Italy; 3Dipartimento di Cardiologia Ospedale Giovan Battista Grassi, Rome, Italy;
4Divisione di Cardiochirurgia, Università Tor Vergata, Rome, Italy
Background: It is well recognized that inflammation plays a crucial role in
atherosclerotic disease. The aim of this study was to assess whether in patients severe
carotid stenosis and non significant coronary artery disease undergoing carotid stenting,
inflammatory markers predict atherosclerotic disease activity after carotid treatment
Methods: Fifty-five consecutive patients (mean age 69+/-8.3 years, 26 men) with
severe carotid stenosis and non significant coronary artery disease were treated with
carotid stent implantation(CAS).Patients were followed-up for a period of five years
for the occurrence of cardiovascular events.
Results: A significant correlation between quantitative analysis of debris entrapped in
the filters and inflammatory markers was found. Moreover, the number of particles
per filter, the total particles area and the mean particle axis per filter were significant
higher in patients with cardiovascular events at the follow-up as compared to patients
without events (87 vs 32, p=0.006; 50118.7 vs 17782, p=0.002; 33.9 vs 30.2; p= 0.03).
At five-year follow-up we recorded cardiovascular or neurological events in 11 patients
(20%). Higher pre-procedural levels of high-sensitivity C-reactive protein (hs-CRP),
soluble interleukin-6 receptor (SR-IL) and interleukin-6 (IL-6) were significantly
associated with clinical events at follow-up (p=0.0008; p=0.05; and p= 0.02,
respectively). In particular hs-CRP measured at 24 and 48 hours after carotid stenting
showed a significant correlation with clinical events. Also pre-procedural intracellular
adhesion molecule-1 (ICAM-1) and circulating vascular cell adhesion molecule-1
(VCAM-1) blood concentration were significant correlated with a worse prognosis at
follow-up (p=0.04 and p=0.03, respectively).
Conclusion: In patients with severe carotid stenosis and non significant coronary artery
disease, inflammation is associated with atherosclerotic disease activity and a worse
prognosis. IL-6, SR-IL, ICAM-1 e VCAM-1 and hs-CRP levels at baseline, 24 and 48
hours after carotid stenting are predictive of neurological and cardiovascular events at
the follow-up.
TCT-552
Fast track Carotid Surgery is the gold standard for High-risk (HRP) Carotid
Artery Intervention: Five year Cost-effectiveness and Quality Stroke Free
Survival comparison
Sherif Sultan1, 2, Niamh Hynes2, 1
1Vascular & Endovascular Surgery, Western Vascular Institute, Galway, Ireland;
2Galway Clinic, Galway, Ireland
Background: We aim to conciliate CAST, CEA and OMT in high-risk symptomatic
patients. Primary endpoints were stroke, myocardial infarction or death. Secondary
endpoints were cost per QALY, re-intervention rate, and patency.
Methods: From Oct01- Oct08, 847 patients were evaluated with carotid stenosis>60%.
The Predicted Probability of receiving CEA, CAST, or OMT was tabulated for all
patients using multiple logistic regressions, controlling for co-morbidity and anatomical
factors. Propensity scoring was used to adjust for baseline characteristics and selection
bias by matching co-variables, creating a pseudo-randomized control design. From
306 CEA, 39 CAST and 275 OMT, we matched 55 CEA, 34 CAS and 67 OMT by
propensity score. 19 (6.3%) had bilateral interventions. Co-morbidity Severity Score
were similar between groups (p>0.05) All interventions were performed within 14 days
of initial presentation. Duplex ultrasound was the sole preoperative imaging modality
used to quantify plaque-morphology and stenosis.
Results: Following intervention, 5-year stroke-free rate was 99.1%(95%CI 99.6-
99.9%), stroke-free survival was 90.6%(95%CI 85.9%-93.9%) and primary patency
was 94.6%(95%CI 90.5%-97.0%). 5-year stroke-free survival was significantly
improved with CEA (90.6%) compared to OMT (44.3%, p<0.0001). Cox-proportional
hazards ratio showed age >80years (p<0.001), female gender (p<0.04) and echolucent
plaque material (p<0.01) were associated with reduced stroke-free survival. Q-TWiST
and cost per QALY were comparable but in favor of CEA over CAST (p>0.05) and
were significantly improved with CEA compared to OMT (p<0.0001) and CAST
(p<0.001).
Conclusion: OMT does not prevent future stroke in patients with severe carotid artery
disease. Indications for CAST are limited. CEA remains the gold standard in suitable
patients with recently symptomatic carotid artery stenosis with superior 5-year stroke-
free survival compared to CAST or OMT.
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